fbpx

Day

December 3, 2014
CANTERBURY, UK, Dec. 1, 2014 (GLOBE NEWSWIRE) -- Ziarco Group Ltd., a biopharmaceutical company focusing on inflammatory skin diseases, today announced the addition of Mike Grey to its Board of Directors as an independent director. Mr. Grey is Chairman and Chief Executive Officer (CEO) of Reneo Pharmaceuticals, a privately held biotechnology company, and a Venture...
LEXINGTON, Mass., December 2, 2014 /PRNewswire/ -- scPharmaceuticals, Inc., a privately held biopharmaceutical company developing transformative pharmaceutical products for subcutaneous delivery, announced today that Leonard D. Schaeffer has been appointed to scPharmaceutical's board of directors.

News

Professor wants to develop a radioactive precision missile to target brain cancer
21. February 2020
New test exposes dangerous moles
14. February 2020
Asthma is programmed early in life
7. February 2020

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge